Bristol-myers Bolsters Biologics In Medarex Buy

Bristol-Myers is buying biotech firm Medarex for $2.1 billion to bolster the U.S. drugmaker's drug pipeline and capability to produce biologic drugs.

Topics:  medarex   u.s    bristol-myers   buy   
BING NEWS:
  • Bristol-Myers Squibb swallows last of antibody pioneers
    has been swallowed up by a pharmaceutical industry hungry for expertise in biologics. The question now is whether all the low-hanging fruit has been snapped up. The price for Medarex was steep at ...
    09/1/2009 - 1:00 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News